4.6 Article

Synthetic Antibody-Rhamnose Cluster Conjugates Show Potent Complement-Dependent Cell Killing by Recruiting Natural Antibodies

Related references

Note: Only part of the references are listed.
Article Chemistry, Medicinal

Chemical Synthesis of Antibody-Hapten Conjugates Capable of Recruiting the Endogenous Antibody to Magnify the Fc Effector Immunity of Antibody for Cancer Immunotherapy

Kun Zhou et al.

Summary: The development of mAb-hapten conjugates can enhance effector functions of monoclonal antibodies, leading to improved cancer cell killing activity and significant antitumor efficacy in xenograft models.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

General and Robust Chemoenzymatic Method for Glycan-Mediated Site-Specific Labeling and Conjugation of Antibodies: Facile Synthesis of Homogeneous Antibody-Drug Conjugates

Xiao Zhang et al.

Summary: The study introduced a versatile and robust chemoenzymatic method for one-pot site-specific functionalization of antibodies, utilizing selectively modified disaccharide oxazoline derivatives as donor substrates. The method enabled direct labeling and functionalization of antibodies without the need for intermediates and enzyme separation, showing potential for applications in antibody-drug conjugation and beyond.

ACS CHEMICAL BIOLOGY (2021)

Article Biochemical Research Methods

One-Pot Conversion of Free Sialoglycans to Functionalized Glycan Oxazolines and Efficient Synthesis of Homogeneous Antibody-Drug Conjugates through Site-Specific Chemoenzymatic Glycan Remodeling

Chong Ou et al.

Summary: ADCs utilize the specificity of antibodies to deliver toxic drugs for targeted cell killing, and site-specific conjugation methods are crucial for constructing homogeneous ADCs; a facile synthesis of functionalized glycan oxazolines from free sialoglycans and efficient endoglycosidase mutant for site-specific glycan transfer were reported for constructing homogeneous ADCs.

BIOCONJUGATE CHEMISTRY (2021)

Review Oncology

Mechanisms of Therapeutic Antitumor Monoclonal Antibodies

Li-Chung Tsao et al.

Summary: Monoclonal antibodies are a crucial component of cancer therapy, primarily working by stimulating innate immune effector processes. Different therapeutic mAbs targeting various tumor antigens have shown significant efficacy, with a key role of innate immune-mediated mechanisms observed in mAb therapies against different types of cancer, including HER2(+) solid tumors.

CANCER RESEARCH (2021)

Article Chemistry, Multidisciplinary

Synthesis and Biological Evaluation of Shishijimicin A-Type Linker-Drugs and Antibody-Drug Conjugates

K. C. Nicolaou et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

Article Chemistry, Multidisciplinary

Development of α-Gal-Antibody Conjugates to Increase Immune Response by Recruiting Natural Antibodies

Julinton Sianturi et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)

Article Multidisciplinary Sciences

Insights into IgM-mediated complement activation based on in situ structures of IgM-C1-C4b

Thomas H. Sharp et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Biochemistry & Molecular Biology

Augmenting Vaccine Immunogenicity through the Use of Natural Human Anti-rhamnose Antibodies

Md Kamal Hossain et al.

ACS CHEMICAL BIOLOGY (2018)

Article Multidisciplinary Sciences

Modulating IgG effector function by Fc glycan engineering

Tiezheng Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Biochemistry & Molecular Biology

Targeting Tumor Cells by Natural Anti-Carbohydrate Antibodies Using Rhamnose-Functionalized Liposomes

Xuexia Li et al.

ACS CHEMICAL BIOLOGY (2016)

Article Chemistry, Multidisciplinary

Optimal Synthetic Glycosylation of a Therapeutic Antibody

Thomas B. Parsons et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)

Article Medicine, Research & Experimental

Design, Synthesis, and Evaluation of Linker-Duocarmycin Payloads: Toward Selection of HER2-Targeting Antibody-Drug Conjugate SYD985

Ronald C. Elgersma et al.

MOLECULAR PHARMACEUTICS (2015)

Article Biochemistry & Molecular Biology

Rhamnose Glycoconjugates for the Recruitment of Endogenous Anti-Carbohydrate Antibodies to Tumor Cells

Rachael T. C. Sheridan et al.

CHEMBIOCHEM (2014)

Article Multidisciplinary Sciences

Complement Is Activated by IgG Hexamers Assembled at the Cell Surface

Christoph A. Diebolder et al.

SCIENCE (2014)

Article Biochemistry & Molecular Biology

Exploring Binding and Effector Functions of Natural Human Antibodies Using Synthetic Immunomodulators

Charles E. Jakobsche et al.

ACS CHEMICAL BIOLOGY (2013)

Article Chemistry, Multidisciplinary

Chemoenzymatic Glycoengineering of Intact IgG Antibodies for Gain of Functions

Wei Huang et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)

Article Biochemistry & Molecular Biology

L-Rhamnose Antigen: A Promising Alternative to α-Gal for Cancer Immunotherapies

Wenlan Chen et al.

ACS CHEMICAL BIOLOGY (2011)

Article Biochemical Research Methods

Profiling Human Serum Antibodies with a Carbohydrate Antigen Microarray

Oyindasola Oyelaran et al.

JOURNAL OF PROTEOME RESEARCH (2009)

Article Biochemistry & Molecular Biology

Anti-carbohydrate antibodies of normal sera: Findings, surprises and challenges

Margaret E. Huflejt et al.

MOLECULAR IMMUNOLOGY (2009)

Article Multidisciplinary Sciences

Neutralization of HIV-1 by redirection of natural antibodies

Maria F. Perdomo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biochemistry & Molecular Biology

Bifunctional ligands that target cells displaying the αvβ3 integrin

Robert M. Owen et al.

CHEMBIOCHEM (2007)

Article Chemistry, Organic

Design and synthesis of alpha Gal-conjugated peptide T20 as novel antiviral agent for HIV-immunotargeting

KP Naicker et al.

ORGANIC & BIOMOLECULAR CHEMISTRY (2004)